僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Sabatolimab （MBG453） is a high-affinity, humanized, IgG4 （S228P） antibody targeting TIM-3, an inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab is a potential immunosuppression agent that can target TIM-3 on immune and myeloid cells